These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4006474)

  • 61. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers.
    Hsu HJ; Chen CK; Wu MS
    Am J Nephrol; 2009; 29(6):592-7. PubMed ID: 19145074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients.
    Docci D; Capponcini C; Mengozzi S; Baldrati L; Neri L; Feletti C
    Nephron; 1995; 69(3):323-6. PubMed ID: 7753268
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombocytopenia associated with one type of polysulfone hemodialysis membrane: a report of 5 cases.
    De Prada L; Lee J; Gillespie A; Benjamin J
    Am J Kidney Dis; 2013 Jan; 61(1):131-3. PubMed ID: 23083811
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Granulocyte activation during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
    Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hemofiltration: differential indication for hemodialysis with reference to the hemodynamic and metabolic aspects].
    Quellhorst E
    Klin Wochenschr; 1979 Oct; 57(19):1061-8. PubMed ID: 392180
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical experience with polysulfone: 10 years.
    Vanholder R; Van Loo A; Ringoir S
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S13-20. PubMed ID: 7923977
    [No Abstract]   [Full Text] [Related]  

  • 69. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.
    Takouli L; Hadjiyannakos D; Metaxaki P; Sideris V; Filiopoulos V; Anogiati A; Vlassopoulos D
    Ren Fail; 2010 Jan; 32(3):287-93. PubMed ID: 20370442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dialysis membrane-induced neutrophil apoptosis is mediated through free radicals.
    Nahar N; Shah H; Siu J; Colvin R; Bhaskaran M; Ranjan R; Wagner JD; Singhal PC
    Clin Nephrol; 2001 Jul; 56(1):52-9. PubMed ID: 11499659
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
    Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
    Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 73. [Effect of separate ultrafiltration on hemodynamics].
    Iarmolinskiĭ IS; Panteleev SM; Stetsiuk EA
    Urol Nefrol (Mosk); 1983; (1):39-42. PubMed ID: 6829091
    [No Abstract]   [Full Text] [Related]  

  • 74. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.
    Bosch-Panadero E; Mas S; Sanchez-Ospina D; Camarero V; Pérez-Gómez MV; Saez-Calero I; Abaigar P; Ortiz A; Egido J; González-Parra E
    J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hemodynamic studies of diffusive and convective procedures using a polysulfone membrane.
    Schneider H; Liomin E; Streicher E
    Contrib Nephrol; 1985; 46():134-50. PubMed ID: 3924478
    [No Abstract]   [Full Text] [Related]  

  • 77. Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress.
    Kosch M; Levers A; Fobker M; Barenbrock M; Schaefer RM; Rahn KH; Hausberg M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1370-5. PubMed ID: 12808175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure.
    Pichaiwong W; Leelahavanichkul A; Eiam-ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S65-72. PubMed ID: 17044456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Asymmetric triacetate membrane keeps high water flux during ultrafiltration: in vitro study.
    Tange Y; Takesawa S; Yoshitake S
    J Artif Organs; 2017 Dec; 20(4):399-402. PubMed ID: 28685358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers.
    Lanese DM; Alfrey PS; Molitoris BA
    Kidney Int; 1989 Jun; 35(6):1409-12. PubMed ID: 2770120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.